280 related articles for article (PubMed ID: 2885440)
1. Cellular mechanisms of action of atrial natriuretic factor.
Gerzer R; Heim JM; Schütte B; Weil J
Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of action of atrial natriuretic factor: clinical consequences.
Gerzer R; Weil J; Strom T; Müller T
Klin Wochenschr; 1986; 64 Suppl 6():21-6. PubMed ID: 2879064
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
Leitman DC; Murad F
Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
[TBL] [Abstract][Full Text] [Related]
4. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):689-96. PubMed ID: 1346640
[TBL] [Abstract][Full Text] [Related]
5. Is cyclic GMP a clinically useful marker for ANF action?
Heim JM; Gottmann K; Weil J; Haufe MC; Gerzer R
Z Kardiol; 1988; 77 Suppl 2():41-6. PubMed ID: 2841815
[TBL] [Abstract][Full Text] [Related]
6. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
Murad F; Waldman S; Molina C; Bennett B; Leitman D
Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.
Yokota N; Bruneau BG; Kuroski de Bold ML; de Bold AJ
J Clin Invest; 1994 Nov; 94(5):1938-46. PubMed ID: 7962539
[TBL] [Abstract][Full Text] [Related]
8. Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
Hamet P; Tremblay J; Pang SC; Skuherska R; Schiffrin EL; Garcia R; Cantin M; Genest J; Palmour R; Ervin FR
J Hypertens Suppl; 1986 Jun; 4(2):S49-56. PubMed ID: 2873213
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens.
Trachte GJ
J Pharmacol Exp Ther; 1993 Mar; 264(3):1227-33. PubMed ID: 8095549
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase.
Leitman DC; Agnost VL; Tuan JJ; Andresen JW; Murad F
Biochem J; 1987 May; 244(1):69-74. PubMed ID: 2889449
[TBL] [Abstract][Full Text] [Related]
12. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1990 Nov; 255(2):497-503. PubMed ID: 1978729
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
Rodriguez-Pascual F; Miras-Portugal MT; Torres M
Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
[TBL] [Abstract][Full Text] [Related]
14. Non-genomic effects of tamoxifen on the activation of membrane-bound guanylate cyclase GC-A.
Chen ZJ; Vetter M; Chang GD; Liu S; Ding Y; Chang CH
J Pharm Pharmacol; 2003 Nov; 55(11):1539-45. PubMed ID: 14713365
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic factor in spontaneously hypertensive rats: concentration changes with the progression of hypertension and elevated formation of cyclic GMP.
Takayanagi R; Imada T; Grammer RT; Misono KS; Naruse M; Inagami T
J Hypertens Suppl; 1986 Oct; 4(3):S303-7. PubMed ID: 2878070
[TBL] [Abstract][Full Text] [Related]
16. [Physiological and physiopathological aspects of the atrial natriuretic factor].
Hamet P; Tremblay J
Nephrologie; 1987; 8(1):7-12. PubMed ID: 2884582
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.
Waldman SA; Rapoport RM; Murad F
J Biol Chem; 1984 Dec; 259(23):14332-4. PubMed ID: 6150043
[TBL] [Abstract][Full Text] [Related]
18. Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins.
Khurana ML; Pandey KN
Arch Biochem Biophys; 1995 Jan; 316(1):392-8. PubMed ID: 7840642
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic factor reduces cyclic adenosine monophosphate content of human fibroblasts by enhancing phosphodiesterase activity.
Lee MA; West RE; Moss J
J Clin Invest; 1988 Aug; 82(2):388-93. PubMed ID: 2457032
[TBL] [Abstract][Full Text] [Related]
20. Effects of atrial natriuretic factor on renal function and cyclic GMP production.
Blaine EH; Seymour AA; Marsh EA; Napier MA
Fed Proc; 1986 Jun; 45(7):2122-7. PubMed ID: 2872085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
